| Ingredients | Amount Per Serving |
|---|---|
|
(aerial)
(from 120 mg of a 4:1 extract)
(Eyebright PlantPart: aerial Note: from 120 mg of a 4:1 extract )
|
480 mg |
Vegetable Cellulose, Gelatin, Silica, Vegetable Magnesium Stearate
Below is general information about the effectiveness of the known ingredients contained in the product Eyebright. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
INSUFFICIENT RELIABLE EVIDENCE to RATE
Below is general information about the safety of the known ingredients contained in the product Eyebright. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
LIKELY SAFE ...when used orally in amounts commonly found in foods. Eyebright is listed by the Council of Europe as a natural source of food flavoring (4).
POSSIBLY UNSAFE ...when applied into the eyes. Avoid using due to hygienic concerns; eyebright ophthalmic products may be subject to contamination (8,11). There is insufficient reliable information available about the safety of eyebright when used orally in medicinal amounts.
PREGNANCY AND LACTATION:
Insufficient reliable information available; avoid using.
Below is general information about the interactions of the known ingredients contained in the product Eyebright. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Preliminary research in animal models of diabetes suggests that eyebright lowers blood glucose levels (49393). Theoretically, concomitant use of eyebright might require dosing adjustment of anti-diabetes drugs; monitor closely. Some medications used for diabetes include glimepiride (Amaryl), glyburide (DiaBeta, Glynase PresTab, Micronase), insulin, pioglitazone (Actos), rosiglitazone (Avandia), chlorpropamide (Diabinese), glipizide (Glucotrol), tolbutamide (Orinase), and others.
|
Below is general information about the adverse effects of the known ingredients contained in the product Eyebright. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General ...There is a limited amount of information on the adverse effects of eyebright. Orally, eyebright has been reported to cause mental confusion, headache, nausea, constipation, cough, dyspnea, insomnia, and polyuria (4). Topically, eyebright applied to the eye has been reported to cause increased eye pressure, itching, redness, vision changes, and photophobia (4). Ophthalmic eyebright products should be used with caution due to the potential for contamination (8,11).
Gastrointestinal ...Orally, eyebright has been reported to cause nausea and constipation (4).
Genitourinary ...Orally, eyebright has been reported to cause polyuria (4).
Neurologic/CNS ...Orally, eyebright has been reported to cause confusion and headache (4).
Ocular/Otic ...Topically, eyebright has been reported to cause increased ocular pressure, lacrimation, pruritus, redness, swelling of eyelid margins, vision changes, and photophobia when applied to the eyes (4). Ophthalmic eyebright products should be used with caution due to the potential for contamination (8,11).
Pulmonary/Respiratory ...Orally, eyebright has been reported to cause cough, dyspnea, and nasal congestion (4).
